Tenon Medical, Inc. (TNON) Form 8-K — Aug 31, 2026
$TNONForm 8-KItems 1.01, 3.02, 8.01, 9.01Filed Aug 31, 2026, 3:40 PM ET0001213900-26-095686Original filing
Tenon Medical, Inc. closed a private placement with an institutional investor on August 31, 2026, receiving gross proceeds of $2,999,404.59. The deal consisted of pre-funded warrants to purchase 597,610 shares at $5.019 each and Series A warrants to purchase 1,058,517 shares. The Series A warrants carry a $5.02 exercise price, are immediately exercisable, and expire in five years, with the placement documents describing 150% warrant coverage.
Key figures
- Gross Proceeds
- 2999404.59
- Offering Price
- $5.019 per Pre-Funded Warrant; $5.02 per share (Series A warrant exercise price)
- Shares Offered
- Pre-funded warrants for 597,610 shares plus Series A warrants for 1,058,517 shares
- Lockup
- 60-day ban on new equity issuances; 6-month ban on variable rate transactions
- Warrant coverage
- 150%
- Placement agent fee
- 7% of gross proceeds (WallachBeth Capital LLC)
- Series a term years
- 5
- Expense reimbursement cap
- $65,000 (written as 'Seventy Thousand Dollars ($65,000)' in the agreement)
- Beneficial ownership limits
- 4.99% (Series A) / 9.99% (Pre-Funded Warrants), increasable to 9.99% with 61 days' notice
- Prefunded warrant exercise price
- 0.001
- Resale registration filing deadline
- 15 days after Registration Rights Agreement
- Resale registration effectiveness deadline
- 45 days (75 days if SEC full review)
Price after filing
1 day: -0.2%7 days: -17.9%30 days: -39.7%
Close on the filing date to close N calendar days later (from $4.53). Historical, not a forecast.
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.